<DOC>
	<DOCNO>NCT00841945</DOCNO>
	<brief_summary>Prospective multicentric Phase III study , evaluation interest radiotherapy 4 6 cycle CHOP 14 R regimen chemotherapy , patient agressive localize B lymphoma , age 18 75 year .</brief_summary>
	<brief_title>Treatment Aggressive Localized Lymphoma</brief_title>
	<detailed_description>CHOP 14 R regimen chemotherapy good standard treatment agressive localize B lymphoma . Interest radiotheraphy</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Age &gt; 18 &lt; 75 year Diffuse B large cell lymphoma , CD 20+ Ann Arbor stage I II withe bulk &lt; 7 cm stage ou II confirm PETscan No previously treat HIV negative Signed Informed consent Age &lt; 18 &gt; 75 year type lymphoma CD20 negative Ann Arbor stage &gt; II bulk &gt; 7 cm HIV positive Contraindication Rituximab use accord Sm PC Containdication antracyclin cancer history cancer , except situ cancer cervix skin epithelioma Refusal sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Diffuse B larg cell lymphoma</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Radiotherapy</keyword>
</DOC>